Drug Type Small molecule drug |
Synonyms DACA, CRC-88/05, NSC 601316 + [5] |
Target |
Action inhibitors |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19N3O |
InChIKeyXBGNERSKEKDZDS-UHFFFAOYSA-N |
CAS Registry89459-25-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 2 | United Kingdom | 01 Oct 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Austria | 01 Sep 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Denmark | 01 Sep 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | France | 01 Sep 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Germany | 01 Sep 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Italy | 01 Sep 1999 | |
Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Spain | 01 Sep 1999 | |
Colorectal Cancer | Phase 2 | Europe | - | - |
Colorectal Cancer | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | - | - |